David Georges

David Georges is the VP, Finance and Administration at Celyad. David has over 19 years of experience in finance and administration.

David started their career in 1999 as a Methods & Procedures Accounting Analyst at AXA. David then moved to Citi in 2003, where they worked as a Financial Reporting & Consolidation Analyst for EMEA. In 2005, they joined Merck Group as their Financial Controller.

In 2008, David joined DIAsource ImmunoAssays as their CFO & Services Manager. David stayed with the company for 10 years until they joined Celyad in 2018.

David Georges has a Master in Finance from the Louvain School of Management and a Master in Economics from the Université catholique de Louvain.

Some of their coworkers include Philippe Nobels - VP Human Resources, Thomas Lequertier - Head of Cell Therapy Manufacturing Unit, and Eytan Breman - Director of R&D. David Georges reports to Michel Lussier, Interim CEO.